Growth Metrics

InfuSystem Holdings (INFU) EBITDA Margin (2016 - 2025)

InfuSystem Holdings (INFU) has disclosed EBITDA Margin for 16 consecutive years, with 5.41% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBITDA Margin rose 181.0% year-over-year to 5.41%, compared with a TTM value of 4.23% through Dec 2025, up 247.0%, and an annual FY2025 reading of 4.23%, up 247.0% over the prior year.
  • EBITDA Margin was 5.41% for Q4 2025 at InfuSystem Holdings, down from 5.99% in the prior quarter.
  • Across five years, EBITDA Margin topped out at 6.79% in Q2 2025 and bottomed at 2.83% in Q1 2024.
  • Average EBITDA Margin over 5 years is 1.81%, with a median of 2.17% recorded in 2024.
  • Peak annual rise in EBITDA Margin hit 529bps in 2021, while the deepest fall reached -4097bps in 2021.
  • Year by year, EBITDA Margin stood at 2.21% in 2021, then plummeted by -100bps to 0.01% in 2022, then tumbled by -14230bps to 1.49% in 2023, then soared by 341bps to 3.59% in 2024, then skyrocketed by 51bps to 5.41% in 2025.
  • Business Quant data shows EBITDA Margin for INFU at 5.41% in Q4 2025, 5.99% in Q3 2025, and 6.79% in Q2 2025.